Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1545, 2006-01, pp. : 7-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Intensive therapy beneficial in AA amyloidosis
Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. :
Cyclophosphamide pulse therapy enhances survival in renal AA amyloidosis associated with RA
Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. :
Lifibrol: first member of a new class of
By Scharnagl H. Mrz W. Wieland H.
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 5, 1997-05 ,pp. :
Aliskiren: first-in-class antihypertensive a big act to follow
Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. :